Showing 1521-1530 of 2527 results for "".
- Body by BTL: New Campaign Showcases Breadth of BTL Aesthetics Offeringshttps://modernaesthetics.com/news/body-by-btl-new-campaign-showcases-breadth-of-btl-aesthetics-offerings/2472134/BTL Aesthetics is celebrating the brand's innovation with a first-of-its-kind campaign for the professional aesthetics industry emphasizing full body results. The Body by
- New From Cutera: Juliet and Secret RFhttps://modernaesthetics.com/news/new-from-cutera-juliet-and-secret-rf/2472149/Cutera has introduced two new devices to its laser and energy-based device offerings: Juliet™ and Secret RF
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- Milestone Scientific Gears Up To Launch New Botox Delivery Instrumenthttps://modernaesthetics.com/news/milestone-scientific-gears-up-to-launch-new-botox-delivery-instrument/2472162/Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. readies to launch its novel and proprietary cosmetic injection instrument. The new cosmetic injection instrument
- James P. Hartman Tapped as New Vice President and General Manager at Solta Medicalhttps://modernaesthetics.com/news/james-p-hartman-tapped-as-new-vice-president-and-general-manager-at-solta-medical/2472174/James P. Hartman is the new Vice President and general manager at Solta Medical, a division of Valeant Pharmaceuticals North America LLC. Mr. Hartman joined Solta Medical from Merz Aesthetics (a division of
- Congrats! Lisa M. Donofrio, MD Named New ASDS/ASDSA Presidenthttps://modernaesthetics.com/news/congrats-lisa-m-donofrio-md-named-new-asdsasdsapresident/2472179/Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers and the ASDS / ASDSA
- NFL Analyst Deion Sanders Named New Brand Ambassador for Botox Cosmetichttps://modernaesthetics.com/news/nfl-analyst-deion-sanders-named-new-brand-ambassador-for-botox-cosmetic/2472201/NFL analyst and philanthropist Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, is the new brand ambassador for BOTOX® Cosmetic. Allergan also released two vide
- Bonti's Gateway Neuromodulator Performs Well in Phase 2A Studyhttps://modernaesthetics.com/news/bontis-gateway-neuromodulator-performs-well-in-pase-2a-for-glabellar-lines/2472208/Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serot
- ASDS: Seven of 10 Consumers Considering Nips or Tuckshttps://modernaesthetics.com/news/asds-seven-of-10-consumers-considering-plastic-surgery/2472214/Nearly 70 percent of consumers now say they are thinking about getting a cosmetic treatment, according to survey data released by the American Society for Dermatologic Surgery (ASDS). The ASD
- Neothetics, Inc.'s Stock Tumbles Following "Unambiguous" Negative LIPO-202 Resultshttps://modernaesthetics.com/news/neothetics-incs-stock-tumbles-following-unambiguous-negative-lipo-202-results/2472217/Neothetics, Inc.’s LIPO-202 for the reduction of submental subcutaneous fat failed to demonstrate improvement on any efficacy measurements or separation from placebo in a Phase 2 proof-of-concept trial. Neothetics Inc. shares d